| Financial Year |
March 31 2023 |
| Monetary Funds |
222,422,833.06 |
| Held-for-trading Financial Assets |
70,124,301.37 |
| Notes Receivable |
284,748.00 |
| Accounts Receivable |
150,113,420.39 |
| Advances to Suppliers |
2,384,234.52 |
| Other Receivables |
5,610,308.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
69,068,809.18 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,005,065.11 |
| Total Current Assets |
524,013,720.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
102,935,616.03 |
| Investment Properties |
142,036,480.91 |
| Fixed Assetes |
329,335,902.78 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,481,433.63 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,026,915.91 |
| Deferred Income Tax Assets |
125,404.74 |
| Other Non-Current Assets |
1,747,787.66 |
| Sub-Total of Non-Current Assets |
613,613,719.38 |
| Total Assets |
1,137,627,439.76 |
| Short-Term Loans |
45,032,552.42 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
142,872,558.90 |
| Accounts Received In Advance |
1,730,654.26 |
| Employee Compensation Payable |
14,793,693.15 |
| Taxes Payable |
10,361,873.17 |
| Interest Payable |
-- |
| Dividend Payable |
1,417,673.30 |
| Other payables |
130,143,604.13 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,528,382.75 |
| Other Current Liabilities |
753,459.25 |
| Sub-Total of Current Liabilities |
358,026,106.61 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
192,269,362.31 |
| Total Liabilities |
550,295,468.92 |
| Paid-In Capital(Or Share Stock) |
243,000,000.00 |
| Capital Surplus |
15,177,366.41 |
| Surplus Reserve |
58,227,067.42 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
263,383,139.50 |
| Minority Stockholder's Interest |
8,954,527.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
578,377,443.33 |
| Owner's Equity（Stockholder's Equity） |
587,331,970.84 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,137,627,439.76 |
